Xuan Zhang

Xuan Zhang

Auto-generated profile, based on publicly available information

Xuan Zhang

Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2009 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Open access
PDF file
LCLisa A. Cassis
Lisa A. Cassis
MGManisha Gupte
Manisha Gupte
STSarah Thayer
Sarah Thayer
XZXuan Zhang
Xuan Zhang
RCRichard Charnigo
Richard Charnigo
ADAlan Daugherty
Alan Daugherty
Infusion of ANG II in hyperlipidemic mice augments atherosclerosis and causes formation of abdominal aortic aneurysms (AAAs). The purpose of this study was to define the contribution of ANG II-induced hypertension to these vascular pathologies. Male apolipoprotein E (apoE)- and LDL receptor (LDLr)-deficient mice were infused with ANG II (1,000 ng·kg−1·min−1) or norepinephrine (NE; 5.6 mg·kg−1·day−1) for 28 days. Infusion of ANG II or NE increased mean arterial pressure (MAP; ANG II, 133 ± 2.8; NE, 129 ± 13 mmHg) to a similar extent compared with baseline blood pressures (MAP, 107 ± 2 mmHg). Abdominal aortic width increased in both apoE-deficient (apoE−/−) or LDLr-deficient (LDLr−/−) mice infused with ANG II (apoE−/−: 1.4 ± 0.1; LDLr−/−: 1.6 ± 0.2 mm). In contrast, NE did not change diameters of abdominal aortas (apoE−/−: 0.91 ± 0.03; LDLr−/−: 0.87 ± 0.02 mm). Similarly, atherosclerotic lesions in aortic arches were much greater in mice infused with ANG II compared with NE. At a subpressor infusion rate of ANG II (500 ng·kg−1·min−1), AAAs developed in 50% of apoE−/− mice. Alternatively, administration of hydralazine (250 mg/l) to ANG II-infused apoE−/− mice (1,000 ng·kg−1·min−1) lowered systolic blood pressure ( day 28: ANG II, 157 ± 6; ANG II/hydralazine, 135 ± 6 mmHg) but did not prevent AAA formation or atherosclerosis. These results demonstrate that infusion of ANG II to hyperlipidemic mice induces AAAs and augments atherosclerosis independent of increased blood pressure.

1 June 2012 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
MGManisha Gupte
Manisha Gupte
STSean E. Thatcher
Sean E. Thatcher
CBCarine M. Boustany-Kari
Carine M. Boustany-Kari
RSRobin Shoemaker
Robin Shoemaker
FYFrederique Yiannikouris
Frederique Yiannikouris
LCLisa A. Cassis
Lisa A. Cassis
Objectives—: Obesity promotes hypertension, but it is unclear if sex differences exist in obesity-related hypertension. Angiotensin converting enzyme 2 (ACE2) converts angiotensin II (AngII) to angiotensin-(1–7) (Ang-[1–7]), controlling peptide balance. We hypothesized that tissue-specific regulation of ACE2 by high-fat (HF) feeding and sex hormones contributes to sex differences in obesity-hypertension. Methods and Results—: HF-fed females gained more body weight and fat mass than males. HF-fed males exhibiting reduced kidney ACE2 activity had increased plasma angiotensin II levels and decreased plasma Ang-(1–7) levels. In contrast, HF-fed females exhibiting elevated adipose ACE2 activity had increased plasma Ang-(1–7) levels. HF-fed males had elevated systolic and diastolic blood pressure that were abolished by losartan. In contrast, HF-fed females did not exhibit increased systolic blood pressure until females were administered the Ang-(1–7) receptor antagonist, D-Ala-Ang-(1–7). Deficiency of ACE2 increased systolic blood pressure in HF-fed males and females, which was abolished by losartan. Ovariectomy of HF-fed female mice reduced adipose ACE2 activity and plasma Ang-(1–7) levels, and promoted obesity-hypertension. Finally, estrogen, but not other sex hormones, increased adipocyte ACE2 mRNA abundance. Conclusions—: These results demonstrate that tissue-specific regulation of ACE2 by diet and sex hormones contributes to sex differences in obesity-hypertension.

31 March 2015 in Circulation
Verified
Journal Article
Closed access
PDF file
RBRobert C. Bauer
Robert C. Bauer
JTJunichiro Tohyama
Junichiro Tohyama
JCJian Cui
Jian Cui
LCLan Cheng
Lan Cheng
JYJifu Yang
Jifu Yang
MRMuredach P. Reilly
Muredach P. Reilly
Background—: Genome-wide association studies have established ADAMTS7 as a locus for coronary artery disease in humans. However, these studies fail to provide directionality for the association between ADAMTS7 and coronary artery disease. Previous reports have implicated ADAMTS7 in the regulation of vascular smooth muscle cell migration, but a role for and the direction of impact of this gene in atherogenesis have not been shown in relevant model systems. Methods and Results—: We bred an Adamts7 whole-body knockout mouse onto both the Ldlr and Apoe knockout hyperlipidemic mouse models. Adamts7 −/− / Ldlr −/− and Adamts7 −/− / Apoe −/− mice displayed significant reductions in lesion formation in aortas and aortic roots compared with controls. Adamts7 knockout mice also showed reduced neointimal formation after femoral wire injury. Adamts7 expression was induced in response to injury and hyperlipidemia but was absent at later time points, and primary Adamts7 knockout vascular smooth muscle cells showed reduced migration in the setting of tumor necrosis factor-α stimulation. ADAMTS7 localized to cells positive for smooth muscle cell markers in human coronary artery disease lesions, and subcellular localization studies in cultured vascular smooth muscle cells placed ADAMTS7 at the cytoplasm and cell membrane, where it colocalized with markers of podosomes. Conclusions—: These data represent the first in vivo experimental validation of the association of Adamts7 with atherogenesis, likely through modulation of vascular cell migration and matrix in atherosclerotic lesions. These results demonstrate that Adamts7 is proatherogenic, lending directionality to the original genetic association and supporting the concept that pharmacological inhibition of ADAMTS7 should be atheroprotective in humans, making it an attractive target for novel therapeutic interventions.

1 July 2008 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
THTracy Henriques
Tracy Henriques
XZXuan Zhang
Xuan Zhang
FYFrederique B. Yiannikouris
Frederique B. Yiannikouris
ADAlan Daugherty
Alan Daugherty
LCLisa A. Cassis
Lisa A. Cassis
Objective— Castration of male apolipoprotein E–deficient (apoE −/− ) mice reduces angiotensin II (Ang II)–induced abdominal aorta aneurysms (AAAs) to that of female mice. The purpose of this study was to determine whether this reduction is attributable to androgen-mediated regulation of aortic Ang II type 1A receptors (AT1aR). Methods and Results— AT1aR mRNA abundance in the AAA-prone region of abdominal aortas was 8-fold greater compared to thoracic aortas of male but not female mice. AT1aR mRNA abundance decreased after castration in abdominal but not thoracic aortas of male mice. Dihydrotestosterone (DHT, 0.16 mg/d) administration to castrated male mice restored AT1aR mRNA abundance in abdominal aortas but had no effect in thoracic aortas. DHT also increased AT1aR mRNA abundance in abdominal aortas from female mice. Castrated male or female apoE −/− mice were administered DHT during infusion of saline or Ang II (1000 ng/kg/min for 28 days). DHT administration did not alter serum cholesterol concentrations, lipoprotein distributions, or atherosclerotic lesion areas in either male or female mice. However, administration of DHT increased AAA incidence in male (27% placebo versus 75% DHT) and female mice (28% placebo versus 64% DHT). Conclusions— Androgen promotes AT1aR mRNA abundance in abdominal aortas associated with increased Ang II–induced AAAs.

1 December 2015 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
PDF file
JLJennie Lin
Jennie Lin
XZXuan Zhang
Xuan Zhang
CXChenyi Xue
Chenyi Xue
HZHanrui Zhang
Hanrui Zhang
MSMichael G. S. Shashaty
Michael G. S. Shashaty
MRMuredach P. Reilly
Muredach P. Reilly
Long noncoding RNAs (lncRNAs) are emerging as key species-specific regulators of cellular and disease processes. To identify potential lncRNAs relevant to acute and chronic renal epithelial injury, we performed unbiased whole transcriptome profiling of human proximal tubular epithelial cells (PTECs) in hypoxic and inflammatory conditions. RNA sequencing revealed that the protein-coding and noncoding transcriptomic landscape differed between hypoxia-stimulated and cytokine-stimulated human PTECs. Hypoxia- and inflammation-modulated lncRNAs were prioritized for focused followup according to their degree of induction by these stress stimuli, their expression in human kidney tissue, and whether exposure of human PTECs to plasma of critically ill sepsis patients with acute kidney injury modulated their expression. For three lncRNAs (MIR210HG, linc-ATP13A4-8, and linc-KIAA1737-2) that fulfilled our criteria, we validated their expression patterns, examined their loci for conservation and synteny, and defined their associated epigenetic marks. The lncRNA landscape characterized here provides insights into novel transcriptomic variations in the renal epithelial cell response to hypoxic and inflammatory stress.

1 April 2011 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
STSean E. Thatcher
Sean E. Thatcher
XZXuan Zhang
Xuan Zhang
DHDeborah A. Howatt
Deborah A. Howatt
Hong S LuHong S Lu
Hong S Lu
SGSusan B. Gurley
Susan B. Gurley
HMHoriuchi M
Horiuchi M
Objective—: The renin-angiotensin system contributes to atherosclerotic lesion formation. Angiotensin-converting enzyme 2 (ACE2) catabolizes angiotensin II (Ang II) to angiotensin 1–7 (Ang-(1–7)) to limit effects of the renin-angiotensin system. The purpose of this study was to define the role of ACE2 in atherosclerosis. Methods and Results—: Male Ace2 −/ y mice in an low-density lipoprotein receptor–deficient background were fed a high-fat diet for 3 months. ACE2 deficiency increased atherosclerotic area ( Ace2 +/ y , 17±1; Ace2 −/ y , 23±2 mm 2 , P <0.002). This increase was blunted by losartan. To determine whether leukocytic ACE2 influenced atherosclerosis, irradiated low-density lipoprotein receptor–deficient male mice were repopulated with bone marrow–derived cells from Ace2 +/ y or Ace2 −/ y mice and fed a high-fat diet for 3 months. ACE2 deficiency in bone marrow–derived cells increased atherosclerotic area ( Ace2 +/ y , 1.6±0.3; Ace2 −/ y , 2.8±0.3 mm 2 ; P <0.05). Macrophages from Ace2 −/ y mice exhibited increased Ang II secretion and elevated expression of inflammatory cytokines. Conditioned media from mouse peritoneal macrophages of Ace2 −/ y mice increased monocyte adhesion to human umbilical vein endothelial cells. Incubation of human umbilical vein endothelial cells with Ang II promoted monocyte adhesion, which was blocked by Ang-(1–7). Coinfusion of Ang-(1–7) with Ang II reduced atherosclerosis. Conclusion—: These results demonstrate that ACE2 deficiency in bone marrow–derived cells promotes atherosclerosis through regulation of Ang II/Ang-(1–7) peptides.